TCF12 induces ferroptosis by suppressing OTUB1‐mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma
Cell Biology International · 2024-11 · 48 (11) · 1649-1663
DOI: 10.1002/cbin.12211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 30.06.2024. Verfasst von Yanchun Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Xianyang Hospital of Yan'an University, Xianyang, China. Hauptthemen laut MEDLINE: Ferroptosis, Cisplatin, Mouth Neoplasms, Amino Acid Transport System y+. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Chemotherapy resistance is a major obstacle to effective cancer treatment, and promotion of ferroptosis can suppress cisplatin resistance in tumor cells. TCF12 plays a suppressive role in oral squamous cell carcinoma (OSCC), but whether it participates in the regulation of cisplatin resistance by modulating ferroptosis remains unclear. Here, we found that TCF12 expression was decreased in OSCC cells compared with normal oral cells, and it was reduced in cisplatin (DDP)‐resistant OSCC cells compared with parental cells. Moreover, overexpression of TCF12 sensitized DDP‐resistant cells to DDP by promoting ferroptosis. Intriguingly, silencing TCF12 reversed the promotion effect of the ferroptosis activator RSL3 on ferroptosis and DDP sensitivity, and overexpressing TCF12 antagonized the effect of the ferroptosis inhibitor liproxstatin‐1 on ferroptosis and DDP resistance. Mechanically, TCF12 promoted ubiquitination of SLC7A11 and decreased SLC7A11 protein stability through transcriptional repression of OTUB1, thereby facilitating ferroptosis. Consistently, SLC7A11 overexpression neutralized the promotion effect of TCF12 on ferroptosis and DDP sensitivity. Additionally, upregulation of TCF12 hindered the growth of mouse OSCC xenografts and enhanced the DDP sensitivity of xenografts by inducing ferroptosis. In conclusion, TCF12 enhanced DDP sensitivity in OSCC cells by promoting ferroptosis, which was achieved through modulating SLC7A11 expression via transcriptional regulation of OTUB1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Xianyang Hospital of Yan'an University, Xianyang, China.
Zitieren
APA
Liu, Y., Bai, Q., Pang, N., & Xue, J. (2024). TCF12 induces ferroptosis by suppressing OTUB1‐mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma. Cell Biology International, 48(11), 1649-1663. https://doi.org/10.1002/cbin.12211
Vancouver
Liu Y, Bai Q, Pang N, Xue J. TCF12 induces ferroptosis by suppressing OTUB1‐mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma. Cell Biology International. 2024;48(11):1649-1663. doi:10.1002/cbin.12211
BibTeX
@article{Liu2024,
author = {Liu, Yanchun and Bai, Qin and Pang, Nan and Xue, Jun},
title = {TCF12 induces ferroptosis by suppressing OTUB1‐mediated SLC7A11 deubiquitination to promote cisplatin sensitivity in oral squamous cell carcinoma},
journal = {Cell Biology International},
year = {2024},
volume = {48},
number = {11},
pages = {1649--1663},
doi = {10.1002/cbin.12211}
}
EUVIMED